Combination Chemotherapy in Treating Patients With Breast Cancer
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving drugs at different times or combining more than one drug may
kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for
breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy consisting
of either doxorubicin, cyclophosphamide, or paclitaxel given at different times with that of
combination chemotherapy consisting of doxorubicin plus cyclophosphamide followed by
paclitaxel in treating women with stage II or stage IIIA breast cancer.